We are live on ! Find out more
AEMD icon

Aethlon Medical
AEMD

18 hedge funds and large institutions have $270K invested in Aethlon Medical in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.4% less ownership

Funds ownership: 4.43% → 3.03% (-1.4%)

10% less funds holding

Funds holding: 20 → 18 (-2)

30% less capital invested

Capital invested by funds: $388K → $270K (-$118K)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
18
Holders Change
-2
Holders Change %
-10%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
3
Closed
5
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$12K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$7.32K
2
VF
Virtu Financial
New York
+$7.32K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$4.39K

Top Sellers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
-$41K
2
Two Sigma Investments
Two Sigma Investments
New York
-$27.8K
3
Millennium Management
Millennium Management
New York
-$16K
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$13.2K
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$10.7K

AEMD Hedge Fund Activity: Q2 2023 in Review

18 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q2 2023, worth a combined $270K — down 30% from $388K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of AEMD and 3 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 0 added.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $7.32K. The largest seller was HRT Financial, exiting entirely with an estimated $41K sold.

  • 18 institutional investors held Aethlon Medical (AEMD) as of Q2 2023, down from 20 in Q1 2023.
  • Funds reported $270K of Aethlon Medical stock for Q2 2023, down 30% quarter-over-quarter.
  • 3 funds opened new Aethlon Medical positions in Q2 2023 and 5 closed out, a net change of -2 holders.
  • The largest Aethlon Medical buyer in Q2 2023 was Renaissance Technologies, an estimated $7.32K added.
  • The largest Aethlon Medical seller in Q2 2023 was HRT Financial, an estimated $41K sold.

Based on aggregated 13F filings for Q2 2023.